To further evaluate ROR1 as a therapeutic target, future studies could assess its function in endometriosis-like lesions in vivo, providing an opportunity to validate ROR1’s role in lesion initiation, progression and recurrence. This evidence concerns the gene ROR1 and endometriosis.